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Abstract
Background: Human oxoguanine glycosylase 1 (hOGG1) in base excision repair (BER) pathway plays a vital role in DNA
repair. Numerous epidemiological studies have evaluated the association between hOGG1 Ser326Cys polymorphism and
the risk of cancer. However, the results of these studies on the association remain conflicting. To derive a more precise
estimation of the association, we conducted a meta-analysis.
Methodology/Principal Findings: A comprehensive search was conducted to identify the eligible studies of hOGG1
Ser326Cys polymorphism and cancer risk. We used odds ratios (ORs) with 95% confidence intervals (CIs) to assess the
strength of the association. We found that the hOGG1 Ser326Cys polymorphism was significantly associated with overall
cancer risk (Cys/Cys vs. Ser/Ser: OR=1.19, 95%CI=1.09–1.30, P,0.001; Cys/Cys vs. Cys/Ser+Ser/Ser: OR=1.16, 95%CI=1.08–
1.26, P,0.001). Moreover, in subgroup analyses by cancer types, the stronger significant association between hOGG1
Ser326Cys polymorphism and lung cancer risk was found (Cys/Cys vs. Ser/Ser: OR=1.29, 95%CI=1.16–1.44, P,0.001; Cys/
Cys vs. Cys/Ser+Ser/Ser: OR=1.22, 95%CI=1.12–1.33, P,0.001). The significant effects of hOGG1 Ser326Cys polymorphism
on colorectal, breast, bladder, prostate, esophageal, and gastric cancer were not detected. In addition, in subgroup analyses
by ethnicities, we found that the hOGG1 Ser326Cys polymorphism was associated with overall cancer risk in Asians (Cys/Cys
vs. Ser/Ser: OR=1.21, 95%CI=1.10–1.33, P,0.001).
Conclusions: This meta-analysis showed that hOGG1 326Cys allele might be a low-penetrant risk factor for lung cancer.
Citation: Wei B, Zhou Y, Xu Z, Xi B, Cheng H, et al. (2011) The Effect of hOGG1 Ser326Cys Polymorphism on Cancer Risk: Evidence from a Meta-Analysis. PLoS
ONE 6(11): e27545. doi:10.1371/journal.pone.0027545
Editor: Deodutta Roy, Florida International University, United States of America
Received June 1, 2011; Accepted October 18, 2011; Published November 17, 2011
Copyright:  2011 Wei et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The authors have no support or funding to report.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: xuzq@wuxiph.com
Introduction
DNA damage plays a vital role in carcinogenesis [1], which
generally occurs through different mechanisms such as by-product
of normal cellular metabolism or the result of exposure to
biological and environmental mutagens. DNA damage, if it is not
repaired, could lead to apoptosis or mutation, which may cause
induction of carcinogenesis [1]. It is suggested that reactive oxygen
species (ROS) could induce both base lesions and single strand
breaks in DNA [1]. The 8-hydroxy-2-deoxyguanine (8-OH-dG) is
a major form of DNA damage, which is produced by reactive free
radicals.
The presence of 8-OH-dG in DNA is thought to be a major
cause of G:C to T:A transversion, because 8-OH-dG could direct
the incorporation of adenine as well as cytosine opposite the lesion
[2]. Thus, 8-OH-dG is a highly mutagenic DNA lesion in vivo
[3,4] unless it is repaired prior to DNA replication. The DNA
repair enzyme human oxoguanine glycosylase 1 (hOGG1) is a
DNA glycosylase/AP lyase that has been indicated to play an
important role in preventing carcinogenesis by repairing oxidative
damage to DNA [5]. Specifically, glycosylase/AP lyase could
efficiently catalyze the excision and removal of 8-OH-dG adducts.
HOGG1 may play a vital role in maintaining genome integrity
and preventing the development of cancer.
Genetic variations in hOGG1 gene are increasingly studied for
an elevated cancer risk because of the critical roles in stabilizing
genome integrity. The hOGG1 gene has codon 326 polymor-
phism (Ser326Cys, rs1052133), and Cys326 has lower ability to
prevent mutagenesis by 8-OH-dG than Ser326 in human cells in
vivo [5]. So far, there were so many reports about the associa-
tion of hOGG1 Ser326Cys polymorphism with risk of different
cancers, including breast [6–18], prostate [19–25], pancreatic
[26,27], bladder [28–34], gallbladder [35–38], gastric [39–49],
colorectal [50–63], esophageal [64–68], lung [69–85], cervical
cancers [86,87], and so on [88–101].
One study showed that the hOGG1 Ser326Cys polymorphism
was associated with an increased risk of colorectal cancer (odds
ratio: 2.3; 95% confidence interval: 1.1–5.0), the risk being higher
in younger individuals [60]. Canbay et al [63] found that hOGG1
Ser326Cys polymorphism might be associated with increased risk
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studies [53,54,59] did not show the significant association between
the Ser326Cys polymorphism and colorectal cancer. Numerous
studies and systematic approaches examined the role of the
Ser326Cys polymorphism in lung cancer susceptibility. One meta-
analysis showed that the overall odds ratio of homozygote for the
hOGG1 326Cys allele against those for the hOGG1 326Ser allele
was 1.24 (95% confidence interval: 1.01–1.53), suggesting that the
locus was involved in susceptibility to lung cancer [83]. In contrast,
another meta-analysis reported no significant association [102].
Some studies [15,16] indicated that the Ser326Cys polymorphism
was not associated with breast cancer. However, Sangrajrang et al
[11] found that Thai women with variant allele of hOGG1
were likely to have an increased susceptibility to breast cancer. In
addition, Chen et al [24] found that hOGG1 Ser326Cys
polymorphism was associated with prostate cancer risk whereas
Nock et al [22] did not find the significant association in the total
study population.
On the whole, the results about the association between
hOGG1 Ser326Cys polymorphism and cancer risk were conflict-
ing and inconclusive. To derive a more precise estimation of the
association, we performed a meta-analysis.
Materials and Methods
Identification and eligibility of relevant studies
PubMed (1956 to 30 July 2011) and Embase (1947 to 30 July
2011) database search was performed using following search
terms: ‘‘oxoguanine glycosylase 1, hOGG1 or OGG1’’, ‘‘poly-
morphism or variant’’, and ‘‘cancer, neoplasm or tumor’’.
Additional studies were identified by a hand search of the
references of original studies. In case of the studies with the same
or overlapping data, we selected the most recent ones with the
largest number of subjects. Studies included in this meta-analysis
should meet the following criteria: (a) evaluation the association of
hOGG1 Ser326Cys polymorphism and cancer risk published in
English language, (b) use a case-control design, (c) contain
available genotype frequency, and (d) the distribution of genotypes
in the controls was consistent with Hardy-Weinberg equilibrium
(HWE).
Data extraction
Two investigators independently extracted the data and reached
a consensus on all the items. For each study, the following
characteristics were collected: last name of first author, year of
publication, country of origin, ethnicity, numbers of genotyped
cases and controls. Different ethnic descents were categorized as
Caucasians (at least 80% of Caucasians included), Asians, and
Africans. If a study did not state the ethnic descendent or if it was
not possible to separate participants according to such phenotype,
the group reported was termed ‘‘mixed ethnicity’’. In addition, if
only one cancer type was included in a study in the meta-analysis,
it was combined into the ‘‘mixed cancer’’ group. For study [49]
including subjects of different ethnic groups, data were extracted
separately for each ethnic group whenever possible. Because the
studies [19,31,56,87,103] only provided the information of
genotypes as ‘‘Cys/Cys+Cys/Ser’’ and Ser/Ser without data for
other genotypes, we could only calculate the OR for the dominant
genetic model.
Statistical analysis
The strength of the association between hOGG1 Ser326Cys
polymorphism and cancer risk was measured by odds ratios (ORs)
with 95% confidence intervals (CIs). We first estimated the risks of
the Cys/Cys and Ser/Cys genotypes on risk of cancer, compared
with the wild-type Ser/Ser homozygote, then evaluated the risks of
‘‘Cys/Cys+Ser/Cys vs. Ser/Ser’’ and ‘‘Cys/Cys vs. Ser/Cys+Ser/
Ser’’ on risk of cancer, assuming dominant and recessive effects of
the variant Cys allele, respectively. Subgroup analysis was also
performed based on different ethnicities, cancer types, age, and
sex.
Heterogeneity was evaluated with a chi-square-based Q test
among the studies (P,0.10 was considered significant) [104,105].
When the heterogeneity was present, the random effects model
was used to calculate the pooled OR [106], whereas the fixed
effects model was used in its absence [107]. Sensitivity analysis was
performed to assess the stability of the results.
For control group of each study, the allelic frequency was
calculated, and the observed genotype frequencies of the hOGG1
Ser326Cys polymorphism were assessed for Hardy-Weinberg
equilibrium (HWE) by using the Pearson chi-square test; P,0.05
was considered significant. Funnel plots and Egger’s linear
regression test were used to provide diagnosis of the potential
publication bias [108].
All statistical tests for this meta-analysis were performed with
STATA (version 10.0; Stata Corporation, College Station, TX)
and SPSS for Windows (version 11.0; SPSS, Inc., Chicago, IL).
Results
Study characteristics
For cancer susceptibility related to hOGG1 Ser326Cys
polymorphism, articles were retrieved based on the search criteria.
Study selection process was shown in Figure 1. Among them, the
distribution of genotypes in the controls was not consistent with
HWE in 13 studies, which were excluded in the meta-analysis. 5
additional studies were excluded because of overlapping data.
Finally, a total of 91 case-control studies involving 31,297 cancer
cases and 39,033 controls were included in the meta-analysis. The
characteristics of included studies were summarized in Table S1.
There were 42 studies of Caucasian descendants and 35 studies of
Asian descendants. Cancers were confirmed histologically or
pathologically in most studies. There were 14 studies of colorectal
cancer, 19 studies of lung cancer, 12 studies of breast cancer, 6
studies of bladder cancer, 4 studies of prostate cancer, 11 studies of
gastric cancer, 5 studies of esophageal cancer, 6 studies of head
and neck cancer, 2 studies of gallbladder cancer, and 2 studies of
ALL. There were 57 studies, in which the data on age of cancer
cases and controls were shown in detail. Among them, the age-
matched control subjects were used in 42 studies, which were
included in subgroup analyses by age. 19 studies, which specifically
reported data according to gender, were eligible for subgroup
analyses by sex. In addition, the distribution of genotypes in the
controls was consistent with HWE in all studies (P.0.05).
Quantitative synthesis
The 326Cys allele frequencies in controls of different ethnicities
were calculated. The frequency of the 326Cys allele was 47.07%
(95%CI=43.39–50.75%) among Asian controls, which was
significantly higher than that of Caucasian controls (23.62%;
95%CI=20.43–26.81%, P,0.001; Figure S1).
We carried out a meta-analysis of the hOGG1 Ser326Cys
polymorphism overall, and in subgroups according to cancer types
and ethnic groups under various genetic models (Table S2).
Overall, we found that the hOGG1 Ser326Cys polymorphism was
significantly associated with the risk of cancer (Cys/Cys vs. Ser/
Ser: OR=1.19, 95%CI=1.09–1.30, P,0.001; Cys/Cys vs. Cys/
Ser+Ser/Ser: OR=1.16, 95%CI=1.08–1.26, P,0.001; Table
hOGG1 Ser326Cys Polymorphism and Cancer Risk
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that the hOGG1 Ser326Cys polymorphism was significantly
associated with lung cancer (Cys/Cys vs. Ser/Ser: OR=1.29,
95%CI=1.16–1.44, P,0.001; Cys/Cys vs. Cys/ Ser+Ser/Ser:
OR=1.22, 95%CI=1.12–1.33, P,0.001; Table S2, Figure 2),
but not with colorectal, breast, bladder, prostate, and gastric
cancer. In addition, we found that the hOGG1 Ser326Cys
polymorphism was significantly associated with the risk of head
and neck cancer (Cys/Cys vs. Ser/Ser: OR=1.71, 95%CI=
1.05–2.78, P=0.03).
In subgroup analyses by ethnicities, we found that the hOGG1
Ser326Cys polymorphism was associated with overall cancer
risk in Asian population (Cys/Cys vs. Ser/Ser: OR=1.21,
95%CI=1.10–1.33, P,0.001; Cys/Cys vs. Cys/Ser+Ser/Ser:
OR=1.14, 95%CI=1.03–1.26, P=0.004; Cys/Cys+Cys/Ser vs.
Ser/Ser: OR=1.12, 95%CI=1.05–1.19, P,0.001; Table S2). In
subgroup analyses by age, we found that the hOGG1 Ser326Cys
polymorphism was associated with overall cancer risk among
cancer cases (,60 years) and cancer cases ($60 years), respectively
(Table S3). In addition, in subgroup analyses by sex, we found that
the Ser326Cys polymorphism was not associated with overall
cancer risk among women and men, respectively (Table S3).
Ethnicity-specific effect of hOGG1 Ser326Cys
polymorphism on cancer risk
When the data were analyzed in subgroups of subjects stratified
by ethnicities, we found that the hOGG1 Ser326Cys polymor-
phism was significantly associated with overall cancer risk among
Asians (Cys/Cys vs. Ser/Ser: OR=1.21, 95%CI=1.10–1.33,
P,0.001; Table S2). The results of logistic regression analyses
showed joint effects between Asians and hOGG1 Ser326Cys
polymorphism (P,0.01).
Test of heterogeneity
The heterogeneity was reckoned between each of the studies
using the Q-test. Overall, the significant heterogeneity was found
(Cys/Cys vs. Ser/Ser: Pheterogeneity,0.001; Cys/ Ser vs. Ser/Ser:
Pheterogeneity,0.001; Cys/Cys vs. Cys/Ser+Ser/Ser: Pheterogeneity
,0.001; Cys/Cys+Cys/Ser vs. Ser/Ser: Pheterogeneity,0.001). In
stratified analyses by cancer types, we did not find the significant
heterogeneity for lung cancer under two genetic models (Cys/Cys
vs. Ser/Ser: Pheterogeneity=0.40; Cys/Cys vs. Cys/ Ser+Ser/Ser:
Pheterogeneity=0.40).
Sensitivity analysis
In the sensitivity analysis, the influence of each study on the
pooled OR was examined by repeating the meta-analysis while
omitting each study, one at a time. This procedure confirmed the
stability of the overall result (data not shown). However, in the
subgroup by ethnicities, sensitivity analyses show that P value of Z-
test for statistical significance of the summary OR (Cys/Cys vs.
Cys/Ser+Ser/Ser) among Caucasians is 0.06 when excluding one
study by Obtulowicz et al.
Publication bias
Begg’s funnel plot and Egger’s test were conducted to assess the
publication bias of the literatures. The shape of funnel plots did
not reveal any evidence of funnel plot asymmetry. Egger’s test
further provided statistical evidence of funnel plot symmetry (Cys/
Cys vs. Ser/Ser: P=0.28; Cys/Ser vs. Ser/Ser: P=0.57; Cys/Cys
vs. Cys/Ser+Ser/Ser: P=0.20; Cys/Cys+Cys/Ser vs. Ser/Ser:
P=0.21). The results did not show any evidence of publication
bias.
Discussion
The hOGG1, which is generally involved in DNA repair, has
been studied extensively on its relationship with different types of
cancer, such as breast [6–18], prostate [19–25], pancreatic
[26,27], bladder [28–34], gallbladder [35–38], gastric [39–49],
colorectal [50–63], esophageal [64–68], lung [69–85], cervical
cancers [86,87], and so on [88–101]. Previous conclusions of
numerous studies on the association between the hOGG1
Ser326Cys polymorphism and cancer risk remain conflicting and
contradictory. The conflicting results are possibly because of a
small effect of the Ser326Cys polymorphism on cancer risk or the
relatively low statistical power of published studies. Hence, this
meta-analysis was needed to provide a quantitative approach for
combining the different results.
The present meta-analysis, including 31,297 cancer cases and
39,033 controls, explored the relationship between the Ser326Cys
polymorphism and overall cancer risk. In the meta-analysis, we
found that the hOGG1 Ser326Cys polymorphism was significantly
associated with overall cancer risk. In subgroup analyses by cancer
types, the significant association between the hOGG1 Ser326Cys
polymorphism and lung cancer risk was further detected. This
result was consistent with previous study [109]. In addition, in
subgroup analyses by ethnicities, we found that the hOGG1
Ser326Cys polymorphism was significantly associated with overall
cancer risk in Asian population. However, sensitivity analyses
suggested that the significant association between the Ser326Cys
polymorphism and overall cancer risk among Caucasians lacked
convincing evidence.
The hOGG1 encodes a DNA glycosylase that is thought to be
involved in base excision repair of oxidatively damaged DNA
[110]. The hOGG1 could catalyze the cleavage of the glycosylic
bond between the modified base and the sugar moiety, leaving an
Figure 1. Flow chart of study selection based on the inclusion
and exclusion criteria.
doi:10.1371/journal.pone.0027545.g001
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apyrimidinic site is then incised, and the repair is completed by
successive actions of a phosphodiesterase, a DNA polymerase, and
a DNA liagse [111–113]. With respect to the important roles of
hOGG1 in DNA repair, it is biologically plausible that hOGG1
Ser326Cys polymorphism may modulate the risk of cancer. This
hypothesis was confirmed by our data. In addition, because of the
relatively small sample size on head and neck cancer, the result
about head and neck cancer needed further confirmation.
We did not find that hOGG1 Ser326Cys polymorphism was
significantly associated with cancer risk in Caucasian popula-
tion and other cancer types including breast, prostate,
pancreatic, bladder, gallbladder, gastric, colorectal, and esoph-
ageal cancer, suggesting the influence of the genetic variant may
be masked by the presence of other as-yet unidentified causal
genes involved in carcinogenesis. In addition, we found that the
frequency of the 326Cys allele was 47.07% among Asian
controls, which was significantly higher than that of Caucasian
controls (23.62%, P,0.001), which may also affect the roles of
hOGG1 Ser326Cys polymorphism on cancer risk in Asians and
Caucasians.
Several limitations of the meta-analysis should be addressed.
First, limited data restricted our evaluation on potential gene-gene
interaction. Second, there was not enough data on African
population in this meta-analysis. Third, our results were based on
unadjusted evaluation. In order to provide a more precise
estimation on the basis of adjustment for confounders, well-
designed studies are warranted by taking potential confounders
such as alcohol and smoking into account.
In summary, this meta-analysis provided evidence of the
association between hOGG1 Ser326Cys polymorphism and
cancer risk, supporting the hypothesis that hOGG1 Ser326Cys
polymorphism might be a low-penetrant susceptibility marker of
lung cancer. Moreover, sophisticated gene-gene interaction should
be considered in future analysis, which would lead a better,
comprehensive understanding of the association between hOGG1
Ser326Cys polymorphism and cancer risk.
Supporting Information
Figure S1 Frequencies of the variant alleles among controls
stratified by ethnicities. The‘‘#’’ and ‘‘*’’ represent outlier.
(TIF)
Figure 2. Forest plot of lung cancer risk associated with hOGG1 Ser326Cys polymorphism (for Cys/Cys vs. Ser/Ser). The squares and
horizontal lines correspond to the study-specific OR and 95% CI. The area of the squares reflects the weight (inverse of the variance). The diamond
represents the summary OR and 95% CI.
doi:10.1371/journal.pone.0027545.g002
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hOGG1 Ser326Cys polymorphism (for Cys/Cys vs. Ser/Ser). The
squaresand horizontallines correspondtothe study-specificORand
95% CI. The area of the squares reflects the weight (inverse of the
variance). The diamond represents the summary OR and 95% CI.
(TIF)
Table S1 Characteristics of studies included in the meta-analysis.
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Table S2 Stratified analyses of the hOGG1 Ser326Cys poly-
morphism on cancer risk.
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Table S3 Stratified analyses of the hOGG1 Ser326Cys poly-
morphism on cancer risk by age and sex.
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